替罗非班对冠心病PCI术后肌钙蛋白I水平的影响(3)
第1页 |
参见附件。
[10] Yang YJ, Zhao JL, You SJ, et al. Different effect of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a miniswine model of acute myocardial infarction and reperfusion [J].Heart, 2006, 92: 1131 - 1137.
[11] Dimitrijevic O, Stojcevski BD, Ignjatovic S, et al. Serial measurements of C-reactive protein after acute myocardial infarction in predicting one-year outcome[J]. Int Heart J, 2006,47: 833 - 842.
[12] Gurbel PA, Bliden KP, Tantry US. Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study[J]. J Am Coll Cardiol, 2006, 48: 2186 -2191.
[13] Ortolani P, Marzocchi A, Marrozzini C, et al. Long-term effectiveness of early administration of glycoprotein Ⅱb/Ⅲa agents to real-world patients undergoing primary percutaneous interventions:results of a registry study in an ST-elevation myocardial infarction network[J]. Eur Heart J, 2009, 30: 33 - 43.
[14] Alexander D, Mann N, Ou FS, et al. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative)[J]. Am J Cardiol, 2008, 102: 1335 - 1340.
作者单位:福建省立医院心内科;福建医科大学省立临床医学院
您现在查看是摘要介绍页,详见PDF附件。